To document our products' performance, efficacy, and safety in clinical situations, we plan and coordinate studies in collaboration with universities and private clinics around the world. A variety of different research activities are ongoing within our company initiated study program, as well as within our investigator initiated study program. Within the scope of these extensive research programs, we are dedicated to confirm that our products are safe and reliable, for the benefit of clinicians and their patients, and to secure that we adhere to global and local regulatory demands.
Company Initiated Study program (CIS)
We start a number of pre-market approval studies every year as a part of our Research and Development process. In addition, we plan and initiate on average, 2-3 prospective, multicenter, clinical studies within our Clinical research unit on a yearly basis. See the list of ongoing and recently completed studies within our company initiated studies program, including short descriptions of each study, and links to publicly available information regarding study design and results.
Within Dentsply Sirona Implants, we have long and extensive experience in conducting high quality studies, often with long time follow-up. Our studies are frequently monitored to assure reliability of study data. Our research complies with the requirements of the FDA and the International Committee of Medical Journal Editors (ICMJE). In line with these requirements, as well as for ethical and transparency reasons, information about our company initiated studies is continuously published on the ClinicalTrials.gov website.